LFCR Q4 2025 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q4 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$36M-3.8% YoY

Gross Profit

$14M38.4% margin

Operating Income

$5M14.6% margin

Net Income

-$1M-3.1% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$239M

Total Liabilities

$238M

Stockholders' Equity

$1M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$38M	-3.8%
Gross Profit	$14M	$17M	-19.0%
Operating Income	$5M	$2M	+147.9%
Net Income	-$1M	-$7M	+83.8%